Skip to main content

Table 1 Baseline characteristics of patients undergoing pancreatoduodenectomy according to GNRI categories. (n = 144)

From: The impact of preoperative nutritional status on postoperative outcomes: an insight from Geriatric Nutritional Risk Index in elderly pancreaticoduodenectomy patients

Characteristic

Total

(N = 144)

High/moderate risk

GNRI ≤ 92

(N = 54)

Low risk

92 < GNRI ≤ 98

(N = 35)

No risk

GNRI > 98

(N = 55)

P-value

Age (years), median (IQR)

71 (9)

74.5 (10)a

71 (10)

70 (5)

0.015

Male, n (%)

84 (58.3%)

31 (57.4%)

18 (51.4%)

35 (63.6%)

0.509

BMI (kg/m2), mean ± SD

22.85 ± 3.45

22.11 ± 4.31a

22.68 ± 3.11

23.67 ± 2.44

0.012

Abdominal surgery history, n (%)

29 (20.1%)

13 (24.1%)

6 (17.1%)

10 (18.2%)

0.655

Hypertension, n (%)

74 (51.4%)

27 (50%)

19 (54.3%)

28 (50.9%)

0.921

Diabetes mellitus, n (%)

43 (29.9%)

14 (25.9%)

10 (28.6%)

19 (34.5%)

0.606

Chronic kidney disease, n (%)

12 (8.3%)

6 (11.1%)

2 (5.7%)

4 (7.3%)

0.625

Coronary artery disease, n (%)

27 (18.8%)

9 (16.7%)

7 (20%)

11 (20%)

0.884

Chronic obstructive pulmonary disease, n (%)

7 (4.9%)

4 (7.4%)

1 (2.9%)

2 (3.6%)

0.538

Disease

     

Benign, n (%)

8 (5.6%)

2 (3.7%)

1 (2.9%)

5 (9.1%)

0.460†

Ampulla of vater adenocarcinoma, n (%)

41 (28.5%)

17 (31.5%)

10 (28.6%)

14 (25.5%)

0.784

Biliary adenocarcinoma, n (%)

22 (15.3%)

6 (11.1%)

8 (22.9%)

8 (14.5%)

0.317

Pancreatic adenocarcinoma, n (%)

55 (38.3%)

23 (42.6%)

12 (34.3%)

20 (36.4%)

0.688

Intraductal papillary mucinous neoplasm, n (%)

6 (4.2%)

3 (5.6%)

0 (0%)

3 (5.5%)

0.504†

Neuroendocrine tumor, n (%)

4 (2.8%)

0 (0%)

1 (2.9%)

3 (5.5%)

0.288†

Other malignancy, n (%)

8 (5.6%)

3 (5.6%)

3 (8.6%)

2 (3.6%)

0.524†

CCI, n (%)

0

66 (45.8%)

22 (40.7%)

19 (54.3%)

25 (45.5%)

0.114†

 

1

47 (32.6%)

20 (37%)

7 (20%)

20 (36.4%)

 
 

2

24 (16.7%)

10 (18.5%)

8 (22.9%)

6 (10.9%)

 
 

3

4 (2.8%)

0 (0%)

0 (0%)

4 (7.3%)

 
 

4

2 (1.4%)

1 (1.9%)

1 (2.9%)

0 (0%)

 
 

5

1 (0.7%)

1 (1.9%)

0 (0%)

0 (0%)

 

ASA physical status, n (%)

II

45 (31.3%)

11 (20.4%)a

9 (25.7%)

25 (45.5%)

0.013†

 

III

98 (68.1%)

43 (79.6%)a

26 (74.3%)

29 (52.7%)

 
 

IV

1 (0.7%)

0 (0%)

0 (0%)

1 (1.8%)

 

ECOG, n (%)

0

125 (86.8%)

41 (75.9%)a

31 (88.6%)

53 (96.4%)

0.016†

 

1

16 (11.1%)

11 (20.4%)a

3 (8.6%)

2 (3.6%)

 
 

2

3 (2.1%)

2 (3.7%)

1 (2.9%)

0 (0%)

 

GNRI score, mean ± SD

94.43 ± 9.75

84.30 ± 5.79ab

95.27 ± 1.61a

103.86 ± 4.85

 < 0.001

Preoperative albumin (g/dL), mean ± SD

3.67 ± 0.63

3.05 ± 0.37ab

3.79 ± 0.48a

4.20 ± 0.32

 < 0.001

Preoperative TBIL (mg/dL), median (IQR)

1.5 (2.7)

2.9(3.6)a

1.6(2.4)a

0.8(1.4)

 < 0.001

Preoperative bile drain, n (%)

87 (60.4%)

38 (70.4%)a

28 (80%)a

21 (38.2%)

 < 0.001

  1. †P-values according to Fisher’s exact tests
  2. aSignificantly different versus No risk group by post-hoc comparison
  3. bSignificantly different versus Low risk group by post-hoc comparison
  4. GNRI Geriatric Nutritional Risk Index, IQR interquartile range, BMI body mass index, SD Standard deviation, CCI Charlson Comorbidity Index, ASA American Society of Anesthesiologists, ECOG Eastern Cooperative Oncology Group, TBIL Total bilirrbun